首页> 美国卫生研究院文献>Endocrine Connections >Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients
【2h】

Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients

机译:来自德国和奥地利的538名先天性肾上腺皮质增生患者的基因型/表型相关性:轻度基因型与筛查患者与预筛查患者之间的不一致

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Congenital adrenal hyperplasia (CAH) due to CYP21A2 gene mutations is associated with a variety of clinical phenotypes (salt wasting, SW; simple virilizing, SV; nonclassical, NC) depending on residual 21-hydroxylase activity. Phenotypes and genotypes correlate well in 80–90% of cases. We set out to test the predictive value of CAH phenotype assignment based on genotype classification in a large multicenter cohort. A retrospective evaluation of genetic data from 538 CAH patients (195 screened) collected from 28 tertiary centers as part of a German quality control program was performed. Genotypes were classified according to residual 21-hydroxylase activity (null, A, B, C) and assigned clinical phenotypes correlated with predicted phenotypes, including analysis of Prader stages. Ultimately, concordance of genotypes with clinical phenotypes was compared in patients diagnosed before or after the introduction of nationwide CAH-newborn screening. Severe genotypes (null and A) correlated well with the expected phenotype (SW in 97 and 91%, respectively), whereas less severe genotypes (B and C) correlated poorly (SV in 45% and NC in 57%, respectively). This was underlined by a high degree of virilization in girls with C genotypes (Prader stage >1 in 28%). SW was diagnosed in 90% of screening-positive babies with classical CAH compared with 74% of prescreening patients. In our CAH series, assigned phenotypes were more severe than expected in milder genotypes and in screened vs prescreening patients. Diagnostic discrimination between phenotypes based on genotypes may prove overcome due to the overlap in their clinical presentations.
机译:CYP21A2基因突变引起的先天性肾上腺增生(CAH)与多种临床表型相关(盐消耗,SW;简单除颤,SV;非经典,NC),具体取决于残留的21-羟化酶活性。表型和基因型在80–90%的病例中具有很好的相关性。我们着手在大型多中心队列中基于基因型分类来测试CAH表型分配的预测价值。作为德国质量控制计划的一部分,对来自28个三级中心的538名CAH患者(筛选出195名)的遗传数据进行了回顾性评估。根据残留的21-羟化酶活性(空,A,B,C)对基因型进行分类,并分配与预期表型相关的临床表型,包括对Prader阶段的分析。最终,在引入全国性CAH新生儿筛查之前或之后,对诊断出的基因型与临床表型的一致性进行了比较。严重的基因型(无效和A)与预期的表型相关性很好(SW分别为97和91%),而不太严重的基因型(B和C)的相关性很差(SV分别为45%和NC分别为57%)。 C基因型女孩的高度病毒化强调了这一点(Prader阶段> 1占28%)。 90%筛查阳性的经典CAH婴儿被诊断为SW,而预筛查的患者为74%。在我们的CAH系列中,在较轻的基因型以及筛查患者和预筛查患者中,指定的表型比预期的严重。由于基因型在临床表现上的重叠,可以证明克服了基于基因型的表型之​​间的诊断区别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号